Immunostimulating complexes (ISCOMs) have been prepared from feline leukaemia virus (FeLV) envelope proteins. The ISCOMs were characterized biochemically in SDS-polyacrylamide gel electrophoresis showing the presence of proteins of estimated molecular weights of 15,000, 27,000 and 70,000. Immunoblotting showed that both the transmembrane protein p15E and the external glycoprotein gp70 (making up the gp85 protein) were present in the ISCOM. Furthermore, a degradation product of gp70 with an estimated molecular weight of 32,000 was identified in the immunoblot. The FeLV ISCOM was shown by electron microscopy to have the characteristic cage-like structure of an ISCOM with a mean diameter of 37 nm. About 10% of the total amount of gp70 in the culture fluid was recovered in the ISCOMs. The largest loss was encountered during the sedimentation of the virus. In a preliminary immunization experiment in mice the FeLV ISCOMs elicited after a booster gave a clear-cut immune response against gp70.

*Retroviridae Proteins, Oncogenic, 0 (Antibodies, Monoclonal), 0 (Retroviridae Proteins, Oncogenic), 0 (Viral Envelope Proteins), 0 (Viral Vaccines), 0 (feline leukemia virus vaccine), Animals, Antibodies, Monoclonal/diagnostic use, Blotting, Western, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Immunization, Mice, Support, Non-U.S. Gov't, Viral Envelope Proteins/*analysis/biosynthesis, Viral Vaccines/*analysis/biosynthesis,
Erasmus MC: University Medical Center Rotterdam

Akerblom, L, Strömstedt, K, Höglund, S, Osterhaus, A.D.M.E, & Morein, B. (1989). Formation and characterization of FeLV iscoms. Vaccine, 7(2), 142–146. doi:10.1016/0264-410X(89)90054-6